Abstract
Nanoparticles can be near infrared (NIR)-fluorescent (e.g., gold nanoparticles, quantum dots or carbon nanotubes) or can have magnetic properties (e.g., iron oxide nanoparticles). These optical or magnetic properties can be exploited for use in thermal therapy and molecular imaging. Radiolabeled nanoparticles have proven to be promising tools in the diagnosis and therapy of malignant processes due to their multivalency and as multi-modal imaging agents. Furthermore, these radiopharmaceuticals may function simultaneously as both radiotherapy systems and thermal-ablation systems. This review examines the application of radiolabeled nanoparticles in the development of multifunctional nanosystems for targeted therapy.
Keywords: Metal nanoparticles, radiolabeled nanoparticles, radio-gold nanoparticles, radio-iron oxide nanoparticles, radiocarbon nanotubes, radio-quantum dots, therapeutic radionuclides, multifunctional radiopharmaceuticals.
Current Medicinal Chemistry
Title:Multifunctional Radiolabeled Nanoparticles for Targeted Therapy
Volume: 21 Issue: 1
Author(s): G. Ferro-Flores, B. E. Ocampo-García, C. L. Santos-Cuevas, E. Morales-Avila and E. Azorín-Vega
Affiliation:
Keywords: Metal nanoparticles, radiolabeled nanoparticles, radio-gold nanoparticles, radio-iron oxide nanoparticles, radiocarbon nanotubes, radio-quantum dots, therapeutic radionuclides, multifunctional radiopharmaceuticals.
Abstract: Nanoparticles can be near infrared (NIR)-fluorescent (e.g., gold nanoparticles, quantum dots or carbon nanotubes) or can have magnetic properties (e.g., iron oxide nanoparticles). These optical or magnetic properties can be exploited for use in thermal therapy and molecular imaging. Radiolabeled nanoparticles have proven to be promising tools in the diagnosis and therapy of malignant processes due to their multivalency and as multi-modal imaging agents. Furthermore, these radiopharmaceuticals may function simultaneously as both radiotherapy systems and thermal-ablation systems. This review examines the application of radiolabeled nanoparticles in the development of multifunctional nanosystems for targeted therapy.
Export Options
About this article
Cite this article as:
Ferro-Flores G., Ocampo-García E. B., Santos-Cuevas L. C., Morales-Avila E. and Azorín-Vega E., Multifunctional Radiolabeled Nanoparticles for Targeted Therapy, Current Medicinal Chemistry 2014; 21(1) . https://dx.doi.org/10.2174/09298673113209990218
DOI https://dx.doi.org/10.2174/09298673113209990218 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The ATP-driven Hsp60 Machinery: Biological and Clinical Implications
Current Immunology Reviews (Discontinued) Biosurfactants as a Novel Additive in Pharmaceutical Formulations: Current Trends and Future Implications
Current Drug Metabolism Lipid Metabolism and Mitochondria: Cross Talk in Cancer
Current Drug Targets Cervical Cancer: Will Interventions to HPV Vaccination Reduce Disparities?
Current Women`s Health Reviews Targeting Cellular Proapoptotic Molecules for Developing Anticancer Agents from Marine Sources
Current Drug Targets PEDF as an Emerging Therapeutic Candidate for Osteosarcoma
Current Cancer Drug Targets Current Therapeutic Options for the Treatment of Juvenile Idiopathic Arthritis
Current Rheumatology Reviews Conditionally Replicating Adenoviruses for Cancer Treatment
Current Cancer Drug Targets Neurocysticercosis: The Enigmatic Disease
Central Nervous System Agents in Medicinal Chemistry Meet Our Editorial Board Member
Anti-Cancer Agents in Medicinal Chemistry Hot Melt Extruded and Injection Moulded Dosage Forms: Recent Research and Patents
Recent Patents on Drug Delivery & Formulation Expression, Purification, and Antibody Binding Activity of Human Papillomavirus 16 L1 Protein Fused to Maltose Binding Protein
Protein & Peptide Letters Melatonin Induces Apoptosis and Inhibits the Proliferation of Cancer Cells via Reactive Oxygen Species-mediated MAPK and mTOR Pathways
Clinical Cancer Drugs Engineered Peptides for Applications in Cancer-Targeted Drug Delivery and Tumor Detection
Mini-Reviews in Medicinal Chemistry Generation of Redox Imbalance Mediates the Cytotoxic Effect of Malabaricone-A in a Multidrug Resistant Cell Line
Anti-Cancer Agents in Medicinal Chemistry Experimental Onco-Immunology Revisited
Current Cancer Therapy Reviews Application of a Deep Matrix Factorization Model on Integrated Gene Expression Data
Current Bioinformatics The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Current Cancer Drug Targets HIV-1 Vpr: Enhancing Sensitivity of Tumors to Apoptosis
Current Drug Delivery The Antiprogestogen Mifepristone: A Review
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents